The Effectiveness of a Health Promotion Program for Older People With Post-Covid-19 Sarcopenia

NCT ID: NCT06211686

Last Updated: 2024-01-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-02-01

Study Completion Date

2024-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to investigate the prevalence of sarcopenia in older people with post-COVID-19 living in Ratchatewi district, Bangkok and to test the effectiveness of health promotion program for older people with post-COVID-19 Sarcopenia. The main questions it aim to answer are: • How many is the prevalence of sarcopenia in older people with post-COVID-19 living in Ratchatewi district, Bangkok? • Can the health promotion program improve muscle mass and muscle strength in older people with post-COVID-19 Sarcopenia ? Participants will be asked eating protein supplement one scoop /day and exercising 2 times/week for 3 months.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post COVID-19 Condition

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Phase I: Descriptive survey research Phase II: Quasi-experimental research
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Protein supplement and Resistance exercise

Group Type EXPERIMENTAL

Protein powder and Resistance exercise

Intervention Type OTHER

1. Protein powder supplementation 25-30 g/day
2. Resistance exercise 2 time/week

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Protein powder and Resistance exercise

1. Protein powder supplementation 25-30 g/day
2. Resistance exercise 2 time/week

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Older people with post-COVID-19 sarcopenia aged more than and equal 60 years
* No disabilities
* Able to read, write and communicate Thai langue
* Live in Bangkok
* Moderate post-covid-19 state defined by Thai version of the COVID-19 Yorkshire Rehabilitation Scale
* No soy protein allergy
* Sign inform consent

Exclusion Criteria

* Severe post-covid-19 state defined by Thai version of the COVID-19 Yorkshire Rehabilitation Scale and complicated health problems
* Disabilities
* Unable to read, write and communicate Thai langue
* Soy protein allergy
* CKD 4 and CKD 5
* Deny or withdraw from project
Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Health Security Office, Thailand

OTHER

Sponsor Role collaborator

Mahidol University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Wanabhorn Tongchom

Principle investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Wanabhorn Tongchom, Doctoral

Role: CONTACT

022012652

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023/918

Identifier Type: OTHER

Identifier Source: secondary_id

MURA2023/918

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Functional Exercise for Sarcopenia
NCT05570136 RECRUITING NA